CPG 7909 Adjuvant plus Hepatitis B Virus Vaccination in HIV-Infected Adults Achieves Long-Term Seroprotection for Up to 5 Years - Cooper, C. L.; Angel, J. B.; Seguin, I.; Davis, H. L.; Cameron, D. W. (Clinical infectious diseases, 2008)
Keywords: Adolescent; Adult; Adults; Antibodies; Biological and medical sciences; Dosage; Double-Blind Method; Female; Geometric mean; Hepatitis; Hepatitis B; Hepatitis B Vaccines - administration & dosage; Hepatitis B Vaccines - immunology; Hepatitis B virus; Hepatology; HIV; HIV Infections - immunology; HIV Infections - prevention & control; HIV/AIDS; Human immunodeficiency virus; Human viral diseases; Humans; Immunization; Immunodeficiencies; Immunodeficiencies. Immunoglobulinopathies; Immunopathology; Infections; Infectious diseases; Liver; Male; Medical sciences; Middle Aged; Oligodeoxyribonucleotides - administration & dosage; Oligodeoxyribonucleotides - immunology; Pharmaceutical preparations; Surface antigens; Time Factors; Treatment Outcome; Vaccination; Vaccination - methods; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Viral hepatitis; Human; Immunopathology; Drug combination; Vaccination; Orthohepadnavirus; Hepatic disease; AIDS; Immune deficiency; Long term; Infection; Prevention; Virus; Viral hepatitis B; Immunoprophylaxis; Hepadnaviridae; Viral disease; Digestive diseases; Adult; Hepatitis B virus